Chembio applies for CLIA waiver for HIV test
This article was originally published in Clinica
Chembio Diagnostics has submitted study data to the US FDA as part of an application for a CLIA waiver for its diagnostic test for HIV. The information is part of an amendment to the firm's 2006 submission to the Center for Devices and Radiological Health division of the agency.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.